Middle ear cholesteatoma: an animal model

Area of Science:

• Otolaryngology
• Experimental Pathology
• Otic Drug Safety

Background:

• Topical otic preparations may cause severe middle ear inflammation.
• Certain ingredients act as nonspecific irritants.
• Clinical implications for otic drug safety are significant.

Purpose of the Study:

• To investigate the chinchilla middle ear response to Cortisporin otic suspension.
• To characterize the histopathological changes induced by the otic preparation.
• To evaluate the potential for cholesteatoma formation.

Main Methods:

• Direct application of Cortisporin otic suspension into chinchilla middle ear bullae (n=32).
• Histologic examination of temporal bones after survival periods of 4 days to 5 months.
• Evaluation of tissue damage, inflammation, and cellular changes.

Main Results:

• All experimental animals exhibited middle ear tissue damage and inflammation.
• Observed changes included cellular proliferation, granulation tissue, bone erosion, and osteoneogenesis.
• Cholesteatoma developed in the majority of animals surviving ≥2 months, mimicking human cholesteatoma behavior.

Conclusions:

• Cortisporin otic suspension acts as a nonspecific irritant, causing significant middle ear pathology.
• Experimental cholesteatoma formation occurred, highlighting risks associated with topical otic preparations.
• Findings underscore the importance of careful otic preparation use to prevent adverse middle ear complications.